Current status of neoadjuvant therapy for locally advanced rectal cancer in Wuhan Union Hospital Cancer Center

[1] Zheng RS(2022)Cancer incidence and mortality in China, 2016 JNCC 2 1-9

[2] Zhang SW(2010)Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes J Clin Oncol 28 256-263

[3] Zeng HM(2018)Rectal cancer, version 2. 2018, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 16 874-901

[4] Wang SM(2012)Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 679-687

[5] Sun KX(2019)Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study Ann Oncol 30 1298-1303

[6] Chen R(2021)Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Lancet Oncol 22 29-42

[7] Gunderson LL(2020)SO-37 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504) Ann Oncol 31 S230-S231

[8] Jessup JM(2021)Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer J Immunother Cancer 9 e003554-64

[9] Sargent DJ(2007)Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome Am J Surg Pathol 31 58-828

[10] Greene FL(2009)Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 821-196

[1] Zheng RS(2022)Cancer incidence and mortality in China, 2016 JNCC 2 1-9

[2] Zhang SW(2010)Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomes J Clin Oncol 28 256-263

[3] Zeng HM(2018)Rectal cancer, version 2. 2018, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw 16 874-901

[4] Wang SM(2012)Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO/ARO/AIO-04 randomised phase 3 trial Lancet Oncol 13 679-687

[5] Sun KX(2019)Long-course preoperative chemoradiation versus 5 × 5 Gy and consolidation chemotherapy for clinical T4 and fixed clinical T3 rectal cancer: long-term results of the randomized Polish II study Ann Oncol 30 1298-1303

[6] Chen R(2021)Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial Lancet Oncol 22 29-42

[7] Gunderson LL(2020)SO-37 Short-term results of VOLTAGE-A: Nivolumab monotherapy and subsequent radical surgery following preoperative chemoradiotherapy in patients with microsatellite stability and microsatellite instability-high, locally advanced rectal cancer (EPOC 1504) Ann Oncol 31 S230-S231

[8] Jessup JM(2021)Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer J Immunother Cancer 9 e003554-64

[9] Sargent DJ(2007)Excellent interobserver agreement on grading the extent of residual carcinoma after preoperative chemoradiation in esophageal and esophagogastric junction carcinoma: a reliable predictor for patient outcome Am J Surg Pathol 31 58-828

[10] Greene FL(2009)Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial Lancet 373 821-196